Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.

Area of Science:

• Neuroimmunology
• Primate models
• Experimental allergic encephalomyelitis

Background:

• Human multiple sclerosis (MS) requires better preclinical models for drug development.
• Current models often fail to capture the complexity of MS pathology and immune responses.

Purpose of the Study:

• To establish and validate a New World primate model, the common marmoset (Callithrix jacchus), for studying multiple sclerosis (MS).
• To assess the utility of this marmoset model for preclinical testing of immunomodulatory drugs.

Main Methods:

• Induction of experimental allergic encephalomyelitis (EAE) in marmosets via myelin immunization.
• Pathological and immunological characterization of EAE lesions.
• In vivo imaging and immunological studies for monitoring disease progression and therapeutic efficacy.

Main Results:

• Marmosets developed chronic, relapsing-remitting EAE with pathological features mirroring human MS lesions.
• The MS-like EAE involved T cells and pathogenic antibodies targeting myelin/oligodendrocyte glycoprotein.
• The model allows for T-cell adoptive transfers and induction of distinct EAE phenotypes.

Conclusions:

• The marmoset EAE model is a valuable preclinical tool for multiple sclerosis research.
• Its close phylogenetic relationship to humans facilitates the translation of findings to novel MS therapeutics.
• The model supports in vivo monitoring for drug efficacy trials.